Coronary Artery Bypass Graft Market Targets a Remarkable US$ 22,765.9 Million by 2033-FMI Projection

Coronary Artery Bypass Graft Market
Coronary Artery Bypass Graft Market

It is anticipated that the coronary artery bypass grafts market sales would grow gradually and reach a projected value of US$ 17,612.1 million in 2023. The industry is predicted to grow to a staggering US$ 22,765.9 million by 2033 within the following ten years. Despite the industry’s 2.6% Compound Annual Growth Rate (CAGR), there is still room for expansion.

This surge can be attributed to the increasing prevalence of coronary artery diseases and the rising demand for advanced cardiac interventions. CABG procedures involve rerouting blood flow around blocked arteries to improve blood supply to the heart muscle. As the global population ages and lifestyle-related cardiovascular issues continue to rise, the demand for effective and innovative coronary artery bypass graft solutions is expected to drive market expansion. Advances in medical technology and surgical techniques further contribute to the positive outlook for the CABG market, positioning it as a critical player in the cardiovascular healthcare landscape.

Coronary artery bypass grafting (CABG) procedures remain a vital intervention for addressing coronary artery disease, ensuring blood flow to the heart muscle. The growing prevalence of cardiovascular diseases, coupled with the global aging population, continues to drive the demand for CABG procedures.

Get a Sample Copy of the Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-1070

Medical advancements, including minimally invasive techniques and innovative materials for grafting, are expected to play a pivotal role in reviving and potentially accelerating market growth. Further research, development, and innovation in this field are essential for improving patient outcomes and reducing the prevalence of cardiovascular conditions worldwide.

Key Takeways:

  1. Steady Growth: The Coronary Artery Bypass Graft (CABG) market is experiencing a consistent expansion, primarily due to the ongoing demand for coronary artery disease interventions.
  2. Growing Cardiovascular Disease Prevalence: The market is driven by the increasing prevalence of cardiovascular diseases, which necessitate CABG procedures to ensure proper blood flow to the heart muscle.
  3. Global Aging Population: As the world’s population ages, the demand for CABG procedures is expected to continue rising, especially among elderly individuals who are more susceptible to heart-related conditions.
  4. Medical Advancements: Ongoing advancements in minimally invasive surgical techniques and innovative grafting materials hold promise for enhancing patient outcomes and potentially accelerating market growth.
  5. Research and Development: Continued research and innovation in the field are crucial for improving cardiac care and reducing the global burden of cardiovascular diseases.
  6. Potential for Further Innovation: The CABG market offers opportunities for further innovation and development, driven by a commitment to enhancing treatment options and patient outcomes.

Key Companies:

  • Medtronic
  • TERUMO CORPORATION
  • Guidant Group
  • MAQUET Holding B.V. & Co. K.G.
  • Vitalitec International, Inc.
  • Novadaq Technologies Inc.
  • KARL STORZ GmbH & Co. K.G.
  • Edwards Lifesciences
  • Genesee Biomedical Inc.
  • Sorin Group

Unleash Potential: Craft Your Customized Report Now:
https://www.futuremarketinsights.com/customization-available/rep-gb-1070

Key Segments

By Technology:

  • Off-pump CABG
  • On-pump CABG
  • Others

By Procedure:

  • Single CABG surgery
  • Double CABG surgery
  • Triple CABG surgery
  • Quadruple CABG surgery
  • Others

By End User:

  • Hospitals
  • Cardiology Clinics
  • Research Institutes
  • Others

By Region:

  • North America
  • Latin America
  • Asia Pacific
  • Europe
  • Middle East and Africa

Author By:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Nandini Singh Sawlani   

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedInTwitterBlogs | YouTube

Leave a comment

Your email address will not be published. Required fields are marked *